188 related articles for article (PubMed ID: 37229629)
1. Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer.
James CA; Baer JM; Zou C; Panni UY; Knolhoff BL; Hogg GD; Kingston NL; Kang LI; Lander VE; Luo J; Tao Y; Watson MA; Aft R; Fields RC; Hawkins WG; DeNardo DG
Cancer Immunol Res; 2023 Aug; 11(8):1055-1067. PubMed ID: 37229629
[TBL] [Abstract][Full Text] [Related]
2. Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance.
Meyer MA; Baer JM; Knolhoff BL; Nywening TM; Panni RZ; Su X; Weilbaecher KN; Hawkins WG; Ma C; Fields RC; Linehan DC; Challen GA; Faccio R; Aft RL; DeNardo DG
Nat Commun; 2018 Mar; 9(1):1250. PubMed ID: 29593283
[TBL] [Abstract][Full Text] [Related]
3. Cell-autonomous FLT3L shedding via ADAM10 mediates conventional dendritic cell development in mouse spleen.
Fujita K; Chakarov S; Kobayashi T; Sakamoto K; Voisin B; Duan K; Nakagawa T; Horiuchi K; Amagai M; Ginhoux F; Nagao K
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14714-14723. PubMed ID: 31262819
[TBL] [Abstract][Full Text] [Related]
4. Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells.
He M; Soni B; Schwalie PC; Hüsser T; Waltzinger C; De Silva D; Prinz Y; Krümpelmann L; Calabro S; Matos I; Trumpfheller C; Bacac M; Umaña P; Levesque MP; Dummer R; van den Broek M; Gasser S
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688559
[TBL] [Abstract][Full Text] [Related]
5. Identification of dendritic cell precursor from the CD11c
In H; Park JS; Shin HS; Ryu SH; Sohn M; Choi W; Park S; Hwang S; Park J; Che L; Kim TG; Chu MK; Na HY; Park CG
Front Immunol; 2023; 14():1179981. PubMed ID: 38094300
[TBL] [Abstract][Full Text] [Related]
6. The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity.
Saito Y; Komori S; Kotani T; Murata Y; Matozaki T
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454882
[TBL] [Abstract][Full Text] [Related]
7. Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103
Zhou Y; Slone N; Chrisikos TT; Kyrysyuk O; Babcock RL; Medik YB; Li HS; Kleinerman ES; Watowich SS
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32273347
[TBL] [Abstract][Full Text] [Related]
8. Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling.
Makino K; Long MD; Kajihara R; Matsueda S; Oba T; Kanehira K; Liu S; Ito F
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101945
[TBL] [Abstract][Full Text] [Related]
9. Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor.
Tjomsland V; Spångeus A; Sandström P; Borch K; Messmer D; Larsson M
PLoS One; 2010 Oct; 5(10):e13441. PubMed ID: 20976171
[TBL] [Abstract][Full Text] [Related]
10. Sepsis Inflammation Impairs the Generation of Functional Dendritic Cells by Targeting Their Progenitors.
Lu J; Sun K; Yang H; Fan D; Huang H; Hong Y; Wu S; Zhou H; Fang F; Li Y; Meng L; Huang J; Bai Z
Front Immunol; 2021; 12():732612. PubMed ID: 34566996
[TBL] [Abstract][Full Text] [Related]
11. Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy.
Prokopi A; Tripp CH; Tummers B; Hornsteiner F; Spoeck S; Crawford JC; Clements DR; Efremova M; Hutter K; Bellmann L; Cappellano G; Cadilha BL; Kobold S; Boon L; Ortner D; Trajanoski Z; Chen S; de Gruijl TD; Idoyaga J; Green DR; Stoitzner P
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33408092
[TBL] [Abstract][Full Text] [Related]
12. GM-CSF, Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2.
Lellahi SM; Azeem W; Hua Y; Gabriel B; Paulsen Rye K; Reikvam H; Kalland KH
Front Immunol; 2022; 13():1058963. PubMed ID: 36713392
[TBL] [Abstract][Full Text] [Related]
13. Augmenting E Protein Activity Impairs cDC2 Differentiation at the Pre-cDC Stage.
Bajana S; Thomas K; Georgescu C; Zhao Y; Wren JD; Kovats S; Sun XH
Front Immunol; 2020; 11():577718. PubMed ID: 33391258
[TBL] [Abstract][Full Text] [Related]
14. Tissue-Specific Factors Differentially Regulate the Expression of Antigen-Processing Enzymes During Dendritic Cell Ontogeny.
Mahiddine K; Hassel C; Murat C; Girard M; Guerder S
Front Immunol; 2020; 11():453. PubMed ID: 32296417
[TBL] [Abstract][Full Text] [Related]
15. Human Blood CD1c+ Dendritic Cells Encompass CD5high and CD5low Subsets That Differ Significantly in Phenotype, Gene Expression, and Functions.
Yin X; Yu H; Jin X; Li J; Guo H; Shi Q; Yin Z; Xu Y; Wang X; Liu R; Wang S; Zhang L
J Immunol; 2017 Feb; 198(4):1553-1564. PubMed ID: 28087664
[TBL] [Abstract][Full Text] [Related]
16. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
[TBL] [Abstract][Full Text] [Related]
17. Clonal lineage tracing reveals shared origin of conventional and plasmacytoid dendritic cells.
Feng J; Pucella JN; Jang G; Alcántara-Hernández M; Upadhaya S; Adams NM; Khodadadi-Jamayran A; Lau CM; Stoeckius M; Hao S; Smibert P; Tsirigos A; Idoyaga J; Reizis B
Immunity; 2022 Mar; 55(3):405-422.e11. PubMed ID: 35180378
[TBL] [Abstract][Full Text] [Related]
18. IRF4 and IRF8 Act in CD11c+ Cells To Regulate Terminal Differentiation of Lung Tissue Dendritic Cells.
Bajaña S; Turner S; Paul J; Ainsua-Enrich E; Kovats S
J Immunol; 2016 Feb; 196(4):1666-77. PubMed ID: 26746189
[TBL] [Abstract][Full Text] [Related]
19. Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow.
Grünwald B; Vandooren J; Gerg M; Ahomaa K; Hunger A; Berchtold S; Akbareian S; Schaten S; Knolle P; Edwards DR; Opdenakker G; Krüger A
Mol Cancer Res; 2016 Nov; 14(11):1147-1158. PubMed ID: 27489361
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity?
Tjomsland V; Sandström P; Spångeus A; Messmer D; Emilsson J; Falkmer U; Falkmer S; Magnusson KE; Borch K; Larsson M
BMC Cancer; 2010 Mar; 10():87. PubMed ID: 20214814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
